Spineway — Capital/Financing Update 2017

Jul 12, 2017

LIQUIDITY CONTRACT HALF-YEARLY REPORT

Regarding liquidity contract granted by SPINEWAY to PORTZAMPARC, the liquidity account held the following assets on 30th June 2017:

• § 20 570 shares SPINEWAY,
• § 33,865.96 €.

At implementation (November 4th 2015) , the position of this liquidity contract was :

• § 20 481 shares SPINEWAY,
• § 28,464.45 €
• § Supplementary contribution of 20,000 € at April 21st 2016.

SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLAN FOR SMES) Find out all about Spineway at www.spineway.com

Next communication: 2017 First Semester Sales – 18 July 2017, after market closes

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column. Spineway has an international network of over 50 independent distributors and 90% of its turnover comes from exports. Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), received the OSEO Excellence award as well as the Deloitte Fast 50 award in 2011. Rhône Alpes INPI Patent Innovation Award (2013) – Talent INPI award (2015). ISIN code: FR0011398874 - ALSPW

Investor Relations David Siegrist – Finance Director Tel: +33 (0)4 72 77 01 52 finance.dsg@spineway.com

Financial Communication Jérôme Gacoin / Solène Kennis Tel: +33 (0)1 75 77 54 68 skennis@aelium.fr